Evidence map›Paper›PMID 31138259›Full record

ArticleCell communication and signaling : CCS2019

Novel mutant mouse line emphasizes the importance of protein kinase C theta for CD4

Kerstin Siegmund, Nikolaus Thuille, Nina Posch, Friedrich Fresser, Michael Leitges, Gottfried Baier

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Loss-of-function phenotype of a PKCθCell communication and signaling : CCS · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kerstin SiegmundDepartment for Pharmacology and Genetics, Medical University Innsbruck, Division of Translational Cell Genetics, Peter Mayr Str. 1a, A-6020, Innsbruck, Austria. Kerstin.Siegmund@i-med.ac.at.ORCID 0000-0002-3654-1170
Nikolaus ThuilleDepartment for Pharmacology and Genetics, Medical University Innsbruck, Division of Translational Cell Genetics, Peter Mayr Str. 1a, A-6020, Innsbruck, Austria.
Nina PoschDepartment for Pharmacology and Genetics, Medical University Innsbruck, Division of Translational Cell Genetics, Peter Mayr Str. 1a, A-6020, Innsbruck, Austria.
Friedrich FresserDepartment for Pharmacology and Genetics, Medical University Innsbruck, Division of Translational Cell Genetics, Peter Mayr Str. 1a, A-6020, Innsbruck, Austria.
Michael LeitgesBiotechnology Center of Oslo, Oslo, Norway.
Gottfried BaierDepartment for Pharmacology and Genetics, Medical University Innsbruck, Division of Translational Cell Genetics, Peter Mayr Str. 1a, A-6020, Innsbruck, Austria. Gottfried.Baier@i-med.ac.at.
Innsbruck Medical University · AT

Funding

Austrian Science Fund FWF P 25044Austrian Science Fund FWF P 30324Austrian Science Fund FWF P 31383
6 · The paper itself

Abstract

backgroundThe protein kinase C theta (PKCθ) has an important and non-redundant function downstream of the antigen receptor and co-receptor complex in T lymphocytes. PKCθ is not only essential for activation of NF-κB, AP-1 and NFAT and subsequent interleukin-2 expression, but also critical for positive selection and development of regulatory T lymphocytes in the thymus. Several domains regulate its activity, such as a pseudosubstrate sequence mediating an auto-inhibitory intramolecular interaction, the tandem C1 domains binding diacylglycerol, and phosphorylation at conserved tyrosine, threonine as well as serine residues throughout the whole length of the protein. To address the importance of the variable domain V1 at the very N-terminus, which is encoded by exon 2, a mutated version of PKCθ was analyzed for its ability to stimulate T lymphocyte activation.

methodsT cell responses were analyzed with promoter luciferase reporter assays in Jurkat T cells transfected with PKCθ expression constructs. A mouse line expressing mutated instead of wild type PKCθ was analyzed in comparison to PKCθ-deficient and wild type mice for thymic development and T cell subsets by flow cytometry and T cell activation by quantitative RT-PCR, luminex analysis and flow cytometry.

resultsIn cell lines, the exon 2-replacing mutation impaired the transactivation of interleukin-2 expression by constitutively active mutant form of PKCθ. Moreover, analysis of a newly generated exon 2-mutant mouse line (PKCθ-E2

conclusionTaken together, PKCθ-E2

Indexed as

Lymphocyte ActivationMutationAnimalsCD4-Positive T-LymphocytesHEK293 CellsHumansJurkat CellsMiceMice, Inbred C57BLPhenotypeProtein Kinase C-thetaProtein Kinase C-thetaInterleukin- 2 (IL-2)Protein kinase C theta (PKCθ)Regulatory T cell developmentT lymphocyte signaling and activation

Identifiers

PMID31138259
PMCPMC6537413
OpenAlexW2947686718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.